Health Data Analysis
Data-driven insights from 240M+ rows of federal health data — Medicaid claims, Medicare physician spending, BRFSS surveys, and NHANES clinical results.
High Triglycerides Are Hiding Behind Normal Cholesterol Panels
A significant share of adults who report being told their cholesterol is fine still carry triglyceride levels above 150 mg/dL — a metabolic warning sign strongly linked to cardiovascular risk and insulin resistance that standard cholesterol conversations routinely omit. This gap is clinically meaningful because elevated triglycerides often co-occur with low HDL and predict cardiovascular events independently of LDL. The story is that the cholesterol conversation Americans are having with their doctors may be systematically incomplete.
The Disability Surge Is Concentrated in One Age Group
Weighted BRFSS trend data from 2015–2024 shows that serious difficulty walking (DIFFWALK) and difficulty concentrating (DECIDE) have increased substantially among adults aged 25–44 — a pattern that diverges sharply from older age groups where disability rates have been more stable. This is not the expected story of an aging population accumulating impairment; it is a younger cohort acquiring functional limitations at a pace that will reshape labor force participation and disability program enrollment for decades. The mental-physical co-occurrence in this age band may be the mechanism.
Ophthalmology Swallowed More Medicare Dollars Than All of Psychiatry
A direct comparison of total Medicare payments across specialties reveals that ophthalmology — driven by cataract surgeries and anti-VEGF drug injections — commands a larger share of Part B spending than the entire psychiatry and behavioral health category combined. Policy makers debating mental health parity rarely frame the conversation this way, but the raw payment data makes the disparity impossible to ignore. The tension: Medicare's spending priorities reflect the aging eye more than the aging mind, raising hard questions about where the program's values actually lie.
Medicaid's Addiction Treatment Billing Tripled and Stayed Uneven
Spending on opioid treatment and substance use disorder services billed through Medicaid has surged since 2018, driven by methadone clinic codes (H0020), buprenorphine office visits, and counseling services — but the growth is geographically lopsided in ways that track the overdose crisis only loosely. States with the worst overdose death rates are not always the states with the highest addiction treatment billing, raising hard questions about whether spending is reaching the people who need it most. The gap between crisis severity and treatment access is the story the data can tell.
The ZIP Codes Where No Specialist Exists Within the Directory
Mapping the geographic distribution of specialists in the DAC data exposes entire ZIP code clusters — particularly in rural Great Plains and Appalachian states — where key specialties like cardiology, neurology, and psychiatry have zero enrolled Medicare clinicians. This is not a claims-based access proxy but a hard structural fact: if no clinician is enrolled in Medicare in a given area for a specialty, Medicare beneficiaries in that area face a documented supply gap. The tension: federal rural health programs have spent billions on access, yet the provider directory itself shows the gaps persist.
The Drug That Went From $200 to $2,000 Per Claim in a Decade
A small set of drugs have seen their Medicare cost-per-claim increase by 500% or more between 2013 and 2023 — not because prescribing volume changed, but because list prices climbed while generic competition never materialized. These aren't rare specialty biologics; several are treatments for common chronic conditions that millions of seniors depend on. The tension here is that Medicare's inability to negotiate drug prices for most of this period left beneficiaries exposed to price increases that no other developed country's seniors faced.
Knee and Hip Replacement Costs Vary by 80% Across States
Major joint replacement (DRG 470) is Medicare's single highest-volume elective procedure, and the per-discharge payment Medicare makes varies by nearly 80% from the lowest-cost states to the highest — a gap that cannot be explained by patient complexity alone. This geographic lottery in surgical pricing means a Medicare beneficiary's out-of-pocket cost for the same operation depends largely on their zip code, not their health. The decade-long trend reveals whether CMS bundled payment experiments and price transparency rules have compressed this variation or left it intact.
The Cholesterol Paradox: Normal BMI, Dangerous Lipids
A clinically significant proportion of normal-weight adults (BMI 18.5–24.9) carry total cholesterol above 240 mg/dL or low HDL — lipid profiles that guidelines typically associate with overweight or obese patients. This finding matters because clinical workflows often use BMI as a proxy for cardiovascular risk triage, potentially causing normal-weight patients to be under-screened for dyslipidemia. The provocative gap: if weight is a poor predictor of lipid status in a non-trivial share of the population, the entire BMI-first risk stratification model deserves scrutiny.
Retired Americans Report Better Mental Health Than Employed Ones
When weighted BRFSS data is broken down by employment status, retired adults consistently report fewer days of poor mental health than employed, unemployed, or unable-to-work adults — a finding that inverts the common narrative that work is protective for mental wellbeing. The gap is especially striking when retirement is compared to the 'unable to work' category, which carries the highest mental health burden of any employment group by a wide margin. The interpretive puzzle: is retirement genuinely protective, or are healthier people simply more likely to retire voluntarily while the sickest workers exit the labor force through disability?
Wound Care Became a $10 Billion Medicare Billing Magnet
Wound care and debridement procedure codes have seen some of the fastest spending growth in Medicare Part B over the past decade, fueled by a proliferation of wound care clinics and high-volume individual providers who bill these codes at extraordinary rates. A small number of providers account for an outsized share of total wound care spending, and geographic concentration — particularly in Sun Belt states — suggests that market dynamics, not patient need, are driving utilization. The gap between submitted charges and Medicare payments for these codes is among the widest in the entire program.
Medicaid Drug Injections Reveal a Two-Tier Specialty System
J-code drug administration claims in Medicaid — covering everything from biologics to infused cancer drugs — are heavily concentrated in a small number of states and an even smaller number of high-volume provider organizations, suggesting that access to infused specialty therapies is determined less by clinical need than by provider geography. For health policy researchers, this concentration pattern implies that Medicaid's drug benefit is functionally unavailable to enrollees in states with thin specialty infrastructure. The data may reveal that a handful of urban infusion centers are billing the vast majority of Medicaid's entire injectable drug budget.
Foreign Medical Schools Now Train a Surprising Share of U.S. Specialists
An analysis of the medical school field in the Medicare clinician directory shows that internationally trained physicians — those who attended medical schools outside the traditional U.S. and Canadian institutions — represent a substantial and specialty-skewed share of the Medicare workforce, concentrated in fields like internal medicine, nephrology, and psychiatry. Workforce shortage debates rarely quantify just how dependent certain specialties and states have become on international medical graduates, making this a critical but underreported structural fact. The provocative question is whether the U.S. healthcare system could function at all in certain specialties without continued international recruitment.
The Ten Drugs That Consumed Half of Medicare's Cost Growth Since 2013
Medicare Part D total drug spending grew dramatically from 2013 to 2023, but that growth was not spread evenly — a small number of high-cost drugs drove a disproportionate share of the increase, with some individual drugs accounting for more new spending than entire therapeutic categories did a decade ago. Identifying the specific drugs responsible for the bulk of spending growth reveals which disease areas and manufacturer pricing strategies are actually driving Medicare's drug budget crisis. The provocative detail is that several of these drugs treat conditions with older, cheaper alternatives that millions of other patients still use successfully.
Sepsis Severity Upcoding Looks Different at For-Profit Hospitals
Sepsis DRGs split into three severity tiers — with MCC, with CC, and without CC/MCC — and the proportion of cases coded at the highest-severity tier (which pays roughly 2-3x more) varies dramatically across hospital types and states. The shift toward higher-severity sepsis coding after the Sepsis-3 definition change in 2016 was not uniform, and some states show implausibly high concentrations of MCC-coded sepsis cases. For health economists and CMS auditors, this pattern raises a direct question about whether clinical documentation improvement programs are capturing real severity or manufacturing it.
Anemia Is Hiding in Plain Sight Among Women Who Think They're Fine
A substantial share of non-elderly American women have hemoglobin below clinical thresholds for anemia — and the majority have never been diagnosed with any blood condition, meaning their fatigue, cognitive fog, and reduced capacity are being attributed to stress, aging, or lifestyle rather than a treatable physiological deficit. For clinicians and health journalists, this represents one of the most systematically under-detected conditions in routine care, hiding behind normal-seeming annual checkups. The provocative gap: anemia prevalence by race and income tells a story about whose fatigue gets taken seriously.
Disability Is Rising Fastest Among Adults Under 45
BRFSS data from 2014 to 2024 shows that self-reported difficulty walking, concentrating, and doing errands alone has grown most sharply among adults aged 25–44 — a working-age group that disability policy rarely targets. This trend predates COVID and accelerated through 2023–2024, suggesting something structural rather than pandemic-specific. The unanswered question is whether rising mental health burden, obesity, or collapsing access to care is driving functional decline in people who should be in their prime.
Facility Billing Captured Half of Medicare's Office Visit Dollars
When the same evaluation and management codes are billed at a facility (Place_Of_Srvc = 'F') versus an office, Medicare pays systematically more — and over the past decade, the share of common office visit codes billed in facility settings has climbed significantly, quietly inflating total spending without any change in the underlying service. Health economists and antitrust researchers tracking hospital acquisition of physician practices will find this data provides direct financial evidence of the cost consequences. The unresolved question is whether the shift reflects genuine site-of-care changes or strategic rebilling of the same encounters.
Medicaid Pays for Emergency Rooms Differently in Every State
Emergency department visit codes (99281–99285) reveal enormous variation in both volume and payment rates across states when measured per Medicaid enrollee, suggesting that some states are far more dependent on the ED as a primary care entry point than others. The gap between the highest and lowest states is not subtle — it spans orders of magnitude in per-enrollee spending. This disparity is a direct measure of primary care access failure, yet it rarely appears in state-level Medicaid scorecards.
The States Where Medicare Clinicians Refuse Full Assignment
In a handful of states, a surprisingly large share of Medicare-enrolled clinicians have not committed to accepting Medicare assignment — meaning patients can be balance-billed for the difference between what Medicare pays and what the doctor charges. This pattern is not evenly distributed: it clusters in wealthy coastal markets and in certain high-demand specialties, creating a two-tiered Medicare system that most beneficiaries never knew existed. The stakes are highest for the sickest patients who most need specialist care and have the least ability to shop around.
Medicare Pays 8x More Per Day of Drug Supply in Some States
Dividing total drug cost by total days of supply across states reveals extraordinary geographic variation in the effective cost per day of medication for Medicare beneficiaries — variation that cannot be explained by drug mix alone and persists even when controlling for the most expensive therapeutic categories. States at the top of this distribution are not simply prescribing more expensive drugs; they are paying more per unit of therapeutic time, pointing to pricing, dispensing, or formulary dynamics that differ sharply by geography. This finding challenges the assumption that Medicare's national drug pricing framework produces anything close to uniform costs across its beneficiary population.
Cardiac Stent Patients Pay Twice as Much Out of Pocket in Some States
The difference between average total payment and average Medicare payment per discharge — a proxy for beneficiary out-of-pocket exposure — varies dramatically by state for the same cardiac procedures, with some states showing beneficiary cost-sharing nearly double the national average. This is a story that directly affects Medicare beneficiaries making decisions about where to seek care, and it has received almost no coverage despite being calculable from public data. The provocative gap: Medicare standardizes payments, yet beneficiaries in different states face wildly different financial exposure for identical procedures.
The Waist Measurement That Predicts Risk Better Than BMI
Waist circumference and BMI tell different stories about metabolic risk, and NHANES data shows the divergence is largest among Non-Hispanic Asian adults and older women — groups where BMI systematically underestimates cardiometabolic danger. This matters to clinicians and policymakers because BMI remains the dominant screening tool in clinical guidelines and insurance algorithms, even as waist circumference more accurately predicts diabetes and cardiovascular risk. The tension: the U.S. health system is screening for the wrong number, and the groups being misclassified are the ones least likely to trigger follow-up care.
Flu Shots Follow Income More Faithfully Than Any Other Preventive Measure
Across a decade of BRFSS data, flu vaccination rates show a steeper income gradient than almost any other preventive behavior — and unlike smoking cessation or exercise, the gap has not narrowed despite the ACA's free preventive care mandate. This is a policy anomaly: flu shots are free, widely available, and recommended universally, yet low-income adults receive them at rates 15-20 percentage points below high-income peers. The uncomfortable implication is that cost isn't the binding constraint — something structural about how low-income Americans interact with the healthcare system is.
Chronic Care Management Billing Exploded — In Only a Few States
Chronic care management codes introduced in 2015 were designed to reward primary care providers for coordinating complex patients, but a decade of data reveals that adoption is staggeringly uneven — a small number of states account for a wildly disproportionate share of all CCM billing, while most states show near-zero uptake even by 2023. Policy researchers designing value-based care programs need to understand whether the concentrated adoption reflects genuine care coordination innovation or selective billing optimization by large practice networks. The deeper question is whether CCM's geographic concentration means millions of eligible Medicare patients in low-adoption states are receiving worse coordinated care — or just underbilled care.
Medicaid's Behavioral Health Surge Left the Poorest States Behind
Billing for mental health and substance use services in Medicaid has grown sharply since 2018, but that growth is heavily concentrated in a subset of states — leaving the states with the highest rates of poverty and unmet mental health need near the bottom of the spending distribution. For policymakers, this mismatch between need and investment is a signal that capacity constraints, not patient demand, are the binding constraint on behavioral health access. The data raises a harder question: are low-spending states failing to expand services, or are they simply unable to find providers willing to bill Medicaid rates?
The Credential Behind Your Specialist Visit Is Changing Fast
Mapping credentials (MD, DO, NP, PA, CRNA) within traditionally physician-led specialties reveals that advanced practice providers have achieved majority or near-majority status in several fields that most patients still assume are physician-only, including pain management, dermatology, and certain surgical subspecialties. This finding matters to anyone tracking scope-of-practice legislation, because the workforce data shows the policy debate has already been settled on the ground in many states. The tension is that credential composition varies wildly by state, suggesting the shift is driven by regulation and economics rather than clinical consensus.
The Same Drug Costs Medicare Three Times More in One State
For the most commonly prescribed drugs in Medicare Part D, cost-per-claim varies by as much as 300% between the highest- and lowest-cost states — for the exact same generic drug, in the same year, with no difference in formulation. This geographic pricing spread is one of the least-discussed inefficiencies in American drug policy, and it persists year after year in the data despite Medicare's national formulary structure. The implication that should stop any health policy reader cold: where you live may matter more to your drug costs than whether you take a brand-name or generic medication.
Spinal Fusion Became Medicare's Most Expensive Discretionary Surgery
Spinal fusion procedures have among the highest per-discharge Medicare payments of any elective surgery, and the total volume billed to Medicare has grown steadily over a decade despite persistent evidence that many fusions produce outcomes no better than physical therapy. The data reveals not just the spending trajectory but extreme geographic variation — some states bill spinal fusion to Medicare at rates three to four times higher than others, a pattern that strongly suggests supply-driven demand rather than population health need. The tension worth exploring is that Medicare has no mechanism to question whether an inpatient spinal fusion was clinically necessary before paying the bill.
Prediabetes Is Now the Statistical Norm for Middle-Aged Americans
When HbA1c data from NHANES 2021–2023 are applied to adults aged 40–59, the combined prevalence of prediabetes (HbA1c 5.7–6.4%) and diabetes (HbA1c ≥ 6.5% or diagnosed) likely exceeds 50% — meaning dysglycemia has crossed from risk factor to majority condition in midlife America. For endocrinologists, primary care physicians, and anyone designing population health interventions, this reframes prediabetes from a warning sign to a baseline state requiring a fundamentally different public health response. The uncomfortable implication is that screening guidelines built around 'at-risk' populations may now be obsolete when the majority is at risk.
Education Stopped Protecting Americans From Poor Mental Health
For decades, higher education was one of the strongest predictors of good mental health outcomes — college graduates reported fewer days of poor mental health than any other group. BRFSS data from 2014 to 2024 reveals that this protective effect has eroded sharply, with college-educated adults (especially those under 45) reporting poor mental health days at rates approaching those of adults who never finished high school. The finding challenges the dominant public health narrative that education is a reliable buffer against mental health decline and raises uncomfortable questions about what college graduates are actually experiencing.
The Markup Machine: Ten Procedures Where Charges Are 20x Payment
A subset of Medicare procedures carries submitted charges that are 20 times or more what Medicare actually pays, revealing a pricing fiction that has real consequences for uninsured patients who are billed at chargemaster rates. Investigative journalists and health equity researchers should care because the procedures with the most extreme markups are not random — they cluster in specific specialties and geographies, and the gap has widened over the decade. The deeper tension: Medicare's payment discipline is protecting its own enrollees while the same providers charge uninsured patients astronomical amounts for identical services.
Transitional Care Billing Reveals Which States Actually Discharge Patients Safely
Transitional Care Management codes (99495, 99496) reimburse providers for structured follow-up within 7–14 days of a hospital or facility discharge — and their billing rates across states serve as a proxy for how seriously Medicaid programs invest in preventing costly readmissions. The gap between high-TCM and low-TCM states is likely enormous and almost certainly not explained by clinical need alone, making this a policy story about reimbursement design, not just provider behavior. The uncomfortable implication is that low TCM billing states may be systematically under-investing in the post-discharge window where Medicaid patients are most vulnerable.
The States Where Nurse Practitioners Outnumber Primary Care Doctors
In a growing number of U.S. states, Nurse Practitioners enrolled in Medicare now outnumber Internal Medicine and Family Practice physicians combined — a workforce inversion that would have seemed impossible two decades ago. Health policy analysts have debated NP scope-of-practice laws for years, but nobody has mapped exactly where that tipping point has already been crossed. The data reveals that the NP-majority primary care state is not a future scenario — it already exists in multiple places.
Blood Thinner Prescribing Doubled and the Cost Per Patient Went Up 900%
The transition from warfarin to newer direct oral anticoagulants (DOACs) like apixaban and rivaroxaban is one of the most consequential prescribing shifts in Medicare history — a drug class that doubled in patient reach while the cost per beneficiary increased nearly tenfold. This matters because anticoagulants are among the most commonly prescribed drugs for atrial fibrillation and clot prevention in the elderly, meaning this cost explosion touches millions of the sickest Medicare patients. The unresolved tension is whether the clinical superiority of DOACs over warfarin justifies a cost curve that has dramatically outpaced any measurable improvement in outcomes visible in the prescribing data.
The Hospitals Charging Medicare 8x What It Pays Them
A small cohort of hospitals submits covered charges that are eight or more times what Medicare ultimately pays — a charge-to-payment ratio so extreme it has no clinical justification and exists almost entirely as a negotiating artifact for commercially insured patients. These outlier chargemasters are geographically clustered, often in states with weak all-payer rate regulation, and they have grown more extreme over the decade as chargemaster inflation continues unchecked. The stakes are real: commercially insured patients at these hospitals face bills anchored to those fictional list prices, making Medicare data a proxy for private-market price gouging.
Half of Adults With High Blood Pressure Don't Know They Have It
NHANES takes three measured blood pressure readings in a clinical setting — and a large share of participants who meet hypertension criteria by those readings have never been told by a doctor they have high blood pressure. This 'unaware hypertensive' population skews younger, male, and lower-income, representing a massive missed prevention window before cardiovascular damage accumulates. The gap between measured disease burden and diagnosed disease burden is one of the most consequential numbers in American public health.
Lonely Americans Report Health as Bad as the Chronically Ill
The 2024 BRFSS introduced a loneliness frequency measure (SDLONELY) that, when cross-tabulated against general health status and chronic disease burden, reveals that adults who frequently feel lonely report physical and mental health outcomes comparable to those with diagnosed chronic conditions — even after accounting for age and income. This finding lands in the middle of a national conversation about loneliness as a public health emergency, but with population-level survey data to back it up rather than anecdote. The unanswered question is whether loneliness is a cause of poor health, a consequence of it, or both — and the data can at least map the magnitude of the overlap.
High-Volume Outlier Providers Concentrate Medicare Risk in Ten ZIP Codes
The top 0.1% of individual Medicare providers by total payments account for a disproportionate share of Part B spending, and they are not randomly distributed — they cluster in a handful of ZIP codes in Florida, Texas, and California in patterns that have persisted for the entire 2013–2023 window. Fraud investigators, health policy researchers, and CMS auditors care about this because geographic concentration of extreme billing is a validated predictor of improper payments flagged in OIG reports. What the data cannot tell us — but the pattern demands we ask — is whether this concentration reflects legitimate specialty hubs or something else entirely.
Behavioral Health Integration Billing Went From Zero to Millions Overnight
Behavioral Health Integration codes (99484, 99492, 99493, 99494) were introduced to reimburse primary care practices for coordinating mental health care — and their adoption in Medicaid has followed an explosive, uneven trajectory that reveals exactly which states are investing in integrated care and which have barely started. With mental health workforce shortages making standalone psychiatric care inaccessible for most Medicaid beneficiaries, these codes represent one of the most scalable policy levers available — yet adoption remains concentrated in a handful of states. The provocative finding: the states with the worst documented mental health outcomes are often the ones billing these codes the least.
Psychiatry's Workforce Is Aging Faster Than Any Other Specialty
The Clinician Directory's graduation year field reveals that psychiatry has one of the oldest active workforces in Medicare — a disproportionate share of practicing psychiatrists graduated before 1990, meaning a retirement wave is imminent precisely as the mental health crisis reaches its peak. For mental health policy analysts, this is a five-alarm signal: the supply of psychiatrists is already inadequate, and attrition over the next decade will make it dramatically worse. The unresolved question is whether nurse practitioners and clinical psychologists are graduating fast enough to absorb the coming gap.
GLP-1 Drugs Rewrote Medicare's Entire Drug Spending Curve in Three Years
Semaglutide and related GLP-1 receptor agonists went from a minor line item to one of the fastest-growing cost categories in Medicare Part D between 2020 and 2023, compressing spending growth that previously took a decade into three years. The rate of cost-per-claim escalation for this drug class is unlike anything in the dataset's 11-year history, including the hepatitis C drug wave of 2014-2015. What makes this analytically interesting is that claim volume growth is modest — it's the per-claim price that is doing the damage to the budget.
COVID Erased a Decade of Inpatient Volume and It Never Came Back
Medicare inpatient discharges dropped sharply in 2020 as hospitals canceled elective procedures and patients avoided care — but the data through 2023 reveals that volume never fully recovered to pre-pandemic levels for dozens of high-frequency DRGs. This isn't just a COVID blip; it appears to represent a structural shift in how and where Medicare patients receive care, likely accelerated by the rise of outpatient surgery centers and observation stays. The missing patients represent billions in care that either moved to a different setting or was simply never delivered.
Elevated Liver Enzymes Are Twice as Common in Low-Income Adults
Using directly measured ALT levels from NHANES blood draws, adults in households below 200% of the federal poverty line show roughly double the rate of elevated liver enzymes compared to higher-income adults — a finding that points toward undiagnosed fatty liver disease as a hidden driver of health inequality. This matters because non-alcoholic fatty liver disease rarely causes symptoms until advanced stages, and low-income adults are least likely to receive the incidental lab work that would catch it. The unanswered question is how much of this gap is driven by obesity, alcohol, or metabolic syndrome versus the simple absence of routine screening.
Food Insecurity Predicts Worse Health Than Smoking in 2024
Using the 2024 BRFSS social determinants module, adults who report that food often or usually doesn't last until the end of the month show prevalence rates of fair/poor health, high poor mental health days, and chronic disease that match or exceed those of current smokers — a finding that reframes food insecurity as a primary clinical risk factor, not a social service problem. Health system leaders and payers should care because food insecurity is rarely screened for in clinical settings, yet the 2024 data suggests it may carry greater health burden than behaviors that get far more clinical attention. The provocative gap: hospitals screen for smoking at every visit but almost never ask about food.
The Procedure That Bills More in Florida Than in 49 States Combined
A handful of high-volume procedure codes show extreme geographic concentration in Medicare billing — with Florida alone accounting for a disproportionate share of national totals for certain services. This pattern signals either a genuine demographic anomaly, a regional care culture, or a billing environment that tolerates volume few other states match. The tension worth exploring: when one state consistently dominates a procedure's national billing, that's rarely a coincidence.
One State Pays Ten Times More Per Medicaid Enrollee Than Its Neighbor
When Medicaid provider spending is normalized by enrolled population, the variation across states is not incremental — it is an order of magnitude, with the highest-spending states paying far more per enrollee than the lowest even after accounting for population size. This disparity reflects a combination of benefit generosity, provider availability, managed care penetration, and political choices about what Medicaid should cover. The provocative implication is that where you live determines not just your health outcomes but how much public money is spent keeping you alive.
Women Now Outnumber Men in Five Major Medical Specialties
Across several high-volume Medicare specialties — including nurse practitioner and certain primary care fields — female clinicians now represent the clear majority, while surgery, cardiology, and procedural fields remain 75–85% male. This isn't just a pipeline story; it's a workforce composition shift that is already reshaping which patients get care from whom. The tension worth exploring is whether the feminization of primary care and the masculinization of high-paying procedural fields is widening medicine's internal pay and prestige gap.
Diabetes Drugs Quietly Became Medicare's Biggest Drug Category
Over the past decade, the explosive rise of GLP-1 agonists and SGLT2 inhibitors has pushed diabetes-related drugs to the top of Medicare Part D spending — a shift so gradual it happened without a single headline moment. The cost per claim for newer diabetes drugs has risen faster than almost any other therapeutic category, even as older generics like metformin remain nearly free. This creates a two-tier diabetes drug economy inside Medicare that nobody designed and nobody is governing.
Beneficiary Out-of-Pocket Costs Grew Faster Than Medicare's Own Payments
The gap between total payment (Avg_Tot_Pymt_Amt) and Medicare's share (Avg_Mdcr_Pymt_Amt) — which approximates what beneficiaries owe in deductibles and coinsurance — has grown faster than Medicare's payments themselves across most high-volume DRGs since 2013. For a Medicare patient hospitalized for pneumonia or heart failure, this means a decade of quietly rising cost exposure that nobody announced. The data reveals which conditions are shifting the most financial burden onto the sickest seniors.
Thin Asians Have the Same Metabolic Risk as Obese White Americans
NHANES lab data reveals that Non-Hispanic Asian adults with BMI in the 'normal' range carry HbA1c and triglyceride profiles that match or exceed those of obese Non-Hispanic White adults — exposing a fundamental flaw in how clinicians screen for metabolic disease. This matters because BMI-based screening thresholds were calibrated on European populations, meaning millions of Asian Americans are likely being cleared as healthy when their bloodwork tells a different story. The unanswered tension: if standard BMI cutoffs systematically under-identify metabolic risk in Asian adults, how many people are being denied preventive interventions they need?
Why College Graduates Are Now the Heaviest Drinkers in America
For decades, heavy drinking was associated with lower educational attainment, but BRFSS trend data suggests a striking reversal: college-educated adults — particularly women — now report binge and heavy drinking at rates that match or exceed those with less education. Substance use researchers, employers with college-educated workforces, and health insurers should find this alarming because high-functioning heavy drinking is both harder to detect and more likely to go untreated. The uncomfortable question the data raises is whether the cultural normalization of wine culture and professional stress drinking has created a public health blind spot among the demographic assumed to make the healthiest choices.
Preventive Care Billing Collapsed in 2020 and Never Fully Recovered
Preventive services — annual wellness visits, cancer screenings, and chronic disease management codes — dropped sharply in 2020 as patients avoided clinics, but the data through 2023 suggests many of these codes never returned to their pre-pandemic trajectory. This isn't just a billing story: deferred preventive care translates directly into later-stage disease diagnoses and worse outcomes for Medicare's older population. The uncomfortable question the data raises is whether the pandemic created a latent wave of undetected illness that will show up in spending and mortality figures over the next decade.
Did Medicaid Providers Actually Come Back After COVID?
Comparing the number of unique billing NPIs active per month before COVID (2018–Feb 2020), during the acute phase (Mar–Dec 2020), and in the recovery period (2021–2024) reveals which provider types and states never fully returned to pre-pandemic billing volumes — a proxy for provider exit from the Medicaid market. This is an underreported workforce story: while much attention has focused on clinician burnout and retirements, the Medicaid-specific question of whether low-reimbursement providers stopped billing entirely has received almost no data-driven attention. The uncomfortable implication is that access to Medicaid providers may have permanently contracted in ways that claims volume data can detect before patient surveys do.
The Graduation Year Gap Reveals Medicine's Looming Retirement Wave
Analyzing the graduation year distribution of Medicare-enrolled clinicians shows a pronounced bulge of physicians who graduated in the late 1970s through 1980s — meaning a massive cohort is approaching or already past typical retirement age, with the specialty-level picture even more alarming in fields like urology, general surgery, and cardiovascular disease. Health workforce planners and journalists covering the doctor shortage need to see which specialties face the steepest near-term attrition, not just current supply gaps. The uncomfortable question: are we training enough specialists fast enough to replace the wave that's about to leave?
The Prescribers Writing $1 Million in Drug Claims Each Year
A small cohort of individual prescribers consistently generates over one million dollars in annual Medicare Part D drug costs — and their specialty mix, geographic concentration, and drug choices reveal a hidden architecture of extreme prescribing that standard averages completely obscure. Investigative journalists and health policy researchers should care because these outlier prescribers disproportionately shape national drug spending figures, and whether they represent legitimate high-complexity patient panels or anomalous prescribing deserves scrutiny. The unresolved tension: are these million-dollar prescribers serving genuinely complex, high-need patients, or are they concentrated in a handful of specialties where expensive drugs are prescribed with minimal oversight?
A Handful of Hospitals Dominate Medicare's Inpatient Budget
Across nearly 3,000 IPPS hospitals billing Medicare inpatient services, the concentration of total Medicare payments in the top 1% of facilities has intensified over the past decade in ways that mirror market concentration trends in other industries — yet hospital consolidation is rarely framed through a spending concentration lens. For antitrust researchers, health policy advocates, and journalists covering hospital mergers, this framing recontextualizes consolidation not just as a competition issue but as a federal budget issue. The provocative undercurrent is whether CMS is effectively writing ever-larger checks to an ever-smaller circle of mega-hospital systems while smaller community hospitals lose volume and viability.
Sleep Debt Is Stealing Years From Young Adults
Adults aged 18-29 report the shortest weekday sleep durations of any age group, and those sleeping fewer than 6 hours show PHQ-9 depression scores, BMI values, and hsCRP levels that more closely resemble adults 20 years older — suggesting that chronic short sleep may be accelerating biological aging in young Americans. This matters because young adulthood is when sleep habits solidify, yet it receives almost no clinical attention compared to sleep problems in older adults. The unresolved tension: is poor sleep causing worse health in young adults, or are stressed, depressed young people simply sleeping less?
Childhood Trauma Leaves a Measurable Scar on Adult Health
BRFSS 2024 is the first year to include a comprehensive set of Adverse Childhood Experience questions, and the data reveals that adults who experienced multiple ACEs report dramatically higher rates of depression, poor mental health days, smoking, and chronic disease. This is not a new theory — ACE research has existed for decades — but having population-representative data at scale finally lets us quantify the dose-response relationship between childhood adversity and adult health outcomes. The uncomfortable implication: a large share of America's chronic disease burden may be rooted in preventable childhood trauma.
The Same Procedure Costs Medicare 60% More at a Hospital
For dozens of high-volume procedures, Medicare pays dramatically more when the exact same service is rendered in a facility setting versus a physician's office — a gap that has widened every year since 2013. This site-of-service differential quietly inflates Medicare spending by billions annually, yet most patients have no idea the billing address of their care determines what Medicare pays. The unanswered question: as hospitals acquire private practices and reclassify offices as outpatient departments, is this gap accelerating the cost crisis?
Personal Care Aides Bill More Than Every U.S. Surgeon Combined
T1019 — the HCPCS code for personal care services billed in 15-minute increments — is the single largest line item in Medicaid provider spending, dwarfing surgical procedures, specialty drugs, and hospital physician services combined. Most health journalists and policy analysts focus on drug prices or specialist fees, completely missing that home-based personal care has quietly become the dominant cost driver in the program. The tension: this spending is nearly invisible in mainstream healthcare cost debates, yet it represents a fundamental shift in what Medicaid actually does.
The Credential Creep Quietly Reshaping Who Delivers Your Care
Nurse practitioners and physician assistants now make up a substantial share of Medicare-enrolled clinicians, but their distribution across specialties and states reveals a workforce undergoing a fundamental structural shift. Health workforce researchers and policy reporters should care because this transition affects care quality debates, scope-of-practice laws, and whether patients understand who is actually treating them. The tension worth exploring: are NPs and PAs filling genuine gaps, or are they concentrating in the same well-resourced areas where physician shortages are least acute?
Opioid Prescribing Collapsed — But One Drug Kept Climbing
Aggregate opioid prescribing in Medicare Part D fell sharply after 2016 CDC guidelines, but disaggregating by individual drug reveals that buprenorphine — used for opioid use disorder treatment — climbed steeply even as traditional opioids cratered, and the prescriber base shifted dramatically toward psychiatrists and addiction specialists. This is a genuine policy success story embedded in a crisis narrative, but it raises a pointed question: is the buprenorphine supply keeping pace with actual need, or are prescribers still too concentrated in too few states? The data can reveal both the win and the remaining gap simultaneously.
Sepsis Billing Exploded After a Definition Change — Not an Outbreak
Medicare inpatient sepsis discharges surged dramatically after 2015, the year new Sepsis-3 clinical definitions broadened the diagnostic criteria — yet this surge is rarely acknowledged as a coding and billing phenomenon as much as a clinical one. For anyone analyzing Medicare inpatient trends, this matters because sepsis DRGs carry among the highest payment rates in the entire system, meaning a reclassification-driven volume increase translates directly into billions in additional Medicare spending. The unresolved question is how much of the 'sepsis epidemic' in Medicare data represents genuinely sicker patients versus hospitals learning to document and bill for a newly lucrative diagnosis.
Young Men's Blood Pressure Is the Epidemic No One Is Treating
Men aged 18-39 have among the lowest rates of diagnosed hypertension despite measured blood pressure data suggesting their actual prevalence of Stage 1 or Stage 2 hypertension rivals older age groups — a gap that points to a generation of men systematically avoiding the doctor until damage is done. For cardiologists and public health officials, this represents a preventable stroke and heart attack pipeline that is invisible in claims data because it never gets coded. The tension is stark: the group most likely to have uncontrolled blood pressure is the group least likely to know it or be treated for it.
Cost-Skipping at the Doctor Is Getting More Common, Not Less
Despite a decade of ACA expansion, the share of Americans who skipped a doctor visit due to cost (MEDCOST1) has not converged toward zero — and the pattern across income groups from 2014 to 2024 tells a story that defies the coverage-expansion narrative. Health policy analysts tracking ACA outcomes need this data because the dominant story is that coverage solved access, but cost-skipping persists even among people with insurance. The tension: if coverage expanded but cost-skipping held steady or worsened for certain groups, something in the deductible-and-copay structure is failing them.
Office Visits Cost Medicare 40% More Than You Think They Do
The same evaluation and management office visit codes billed in a hospital outpatient facility pay Medicare significantly more than when billed in a physician's office — a price difference most patients and even many physicians don't realize exists. As hospital systems acquire private practices at record rates, this facility-vs-office payment gap is quietly inflating Medicare Part B spending without adding a single extra service. The tension worth exploring: CMS has tried to close this gap for years, but the data may show the problem is actually getting worse.
Medicaid's Mental Health Spending Boom Nobody Planned For
Behavioral health procedure codes — including psychiatric evaluation, psychotherapy, and crisis intervention — have seen dramatic spending growth since 2020, but the trajectory differs sharply by state and provider type. This matters because the mental health provider shortage means billing growth doesn't automatically translate into more patients getting care; it may instead reflect higher utilization by a smaller pool of providers. The unresolved question is whether Medicaid is successfully expanding mental health access or concentrating payments among a shrinking group of high-volume billers.
Which Medical Schools Produce the Most Underserved-State Doctors?
Every medical school claims a mission of producing physicians who serve communities in need, but the Medicare enrollment directory can test that claim by tracing where graduates of specific schools actually end up practicing. If a school's alumni disproportionately concentrate in high-density urban states while graduates of other schools populate rural or low-clinician states, that's a policy-relevant finding that accreditation bodies and state legislatures rarely quantify. The deeper question is whether DO-granting schools, historically associated with primary care and rural service, actually outperform MD programs on this metric when measured in real enrollment data.
One Drug Ate Medicare's Entire Drug Budget Growth for a Decade
A single drug — or a handful of blockbusters — may account for a disproportionate share of the total dollar increase in Medicare Part D spending between 2013 and 2023, meaning that policy debates about 'drug spending' are really debates about a very small number of molecules. This is the kind of concentration finding that stops a health economist cold, because it reframes the entire cost-control conversation around targeted negotiation rather than broad reform. The unresolved question: now that Medicare can negotiate drug prices under the Inflation Reduction Act, did policymakers pick the right drugs to target first?
Sepsis Is Now Medicare's Single Biggest Expense
Sepsis — a life-threatening immune response to infection — has quietly become the dominant line item in Medicare inpatient spending, driven by both high per-discharge payments and enormous volume. Over the past decade, total Medicare dollars flowing to sepsis DRGs have grown faster than almost any other condition, yet public awareness of this shift is nearly zero. The tension: better sepsis detection guidelines may be inflating case counts, making it impossible to tell whether the disease is genuinely more common or just more frequently diagnosed.
Poor Americans Have Older Blood: The Inflammation Gap
High-sensitivity CRP (hsCRP) is a validated marker of chronic systemic inflammation linked to cardiovascular disease, diabetes, and accelerated biological aging — and NHANES data reveals a striking gradient by income level that persists even after accounting for BMI and smoking status. The gap between the lowest and highest income groups in elevated CRP prevalence tells a story about how poverty doesn't just limit healthcare access; it appears to leave a measurable biological signature in the bloodstream. This finding reframes 'social determinants of health' from a policy abstraction into a concrete, lab-confirmed physiological reality.
Smoking Is Falling — But Who Got Left Behind?
National smoking rates have declined for decades, yet the aggregate trend masks dramatic inequality: when you break down current smoking rates by education, income, and state, certain groups have seen almost no improvement while others have nearly eliminated smoking. Health journalists covering tobacco policy need to know whether progress has been equitable or whether the smoking epidemic has simply migrated to a narrower, harder-to-reach population. The tension: if the easy gains are gone, what does it take to reach the people still smoking at high rates?
Did COVID-19 Permanently Change How Doctors Bill Medicare?
We compare procedure code volumes and spending patterns before (2018–2019), during (2020–2021), and after (2022–2023) the pandemic to identify which billing patterns changed permanently and which returned to pre-pandemic levels.
Young Adults Are Reporting Significantly Worse Mental Health Since 2014
This article tracks trends in self-reported poor mental health days among adults aged 18-34 from 2014 to 2024, comparing their trajectory to older age groups to see if younger Americans are uniquely driving the mental health crisis. It also examines whether the gap between young adults and older cohorts has widened over the decade.
Who Carries the Greater Mental Health Burden: Men or Women?
This post examines the gender gap in mental health burden across BRFSS survey years 2014–2024, measuring how rates of frequent poor mental health days differ between men and women and whether that gap has shifted over time. It also explores which age groups show the starkest disparities, revealing where the burden falls hardest.
How Does Menopause Impact Women's Mental Health Across Stages of Life?
Using nationally representative survey data, this article tracks how women's self-reported mental health shifts across every life stage — with a focus on the perimenopausal and postmenopausal years — and how that trajectory compares to men's at every age.
Who Binge Drinks the Most? Are Young People Binge Drinking More or Less Over Time?
Using BRFSS data from 2014 to 2024, this article tracks binge drinking and heavy drinking rates by age group to see whether the long-assumed pattern of alcohol use peaking in young adulthood has held, shifted, or reversed. It also examines whether trends differ by sex.
Do Women in Midlife Have Higher Rates of Chronic Disease?
Cardiovascular disease, diabetes, and arthritis all increase in prevalence during and after menopause, but how do these rates compare between women and men in the same age bands at the population level? This article maps the chronic disease burden of women aged 45–64 across conditions and states using a decade of BRFSS data.
What Does Medicare Actually Spend on Drugs vs. Doctor Services?
Medicare Part B covers both physician-administered drugs and traditional medical services — we break down how much of Part B spending goes to biologicals and infusions versus procedures, and track how that balance has shifted over a decade.
Is Your Blood Pressure Higher Than You Think?
Compares measured blood pressure readings from NHANES clinical exams against self-reported hypertension diagnoses to expose gaps in awareness and control, segmented by age group, gender, and race/ethnicity.
Do Uninsured Americans Have Worse Lab Results?
Compares key clinical measurements — HbA1c, blood pressure, total cholesterol, and BMI — between insured and uninsured adults to quantify the measurable health toll of lacking coverage in the NHANES 2021–2023 cycle.
Does Exercising Regularly Actually Protect Against Depression?
This article uses BRFSS data to examine the relationship between leisure-time physical activity and poor mental health days, depressive disorder diagnosis, and self-rated health, controlling for age and income. It tracks whether the protective association between exercise and mental health has strengthened over the decade as mental health worsened nationally.
Has Obesity Gotten Worse in Every State Since 2014?
This article maps the trajectory of adult obesity rates across all 50 states plus DC from 2014 through 2024, identifying which states have seen the steepest increases and whether any have managed to flatten or reverse the trend. It also examines whether the gap between the most and least obese states is widening.
Are Non-Physician Providers Taking Over Medicare Billing?
Nurse practitioners, physician assistants, and other advanced practice providers are billing Medicare in growing numbers. We quantify their rise, the procedures they most commonly bill, and how their payment rates compare to physician counterparts.
Are Rural Patients Getting Less Medicare Care Than Urban Ones?
Using rural-urban classification codes, we examine whether patients in rural and small-town America are served by fewer providers, see lower Medicare spending per service, and have access to a narrower range of procedures than their metropolitan counterparts.
Does Poor Sleep Drive Both Depression and Obesity?
Investigates the intersecting relationships between short sleep duration, PHQ-9 depression scores, and obesity using NHANES physical and questionnaire data, revealing how these three risk factors cluster together in the population.
Are Veterans Healthier or Sicker Than Civilians?
This article compares physical health, mental health, chronic disease burden, and health care access between veterans and non-veterans using a decade of BRFSS data. It examines whether the 'healthy soldier effect' holds up over time and across age groups.
Which States Have the Worst Mental Health Crisis?
Using weighted BRFSS data across all survey years, this article ranks every U.S. state by the share of adults reporting 14 or more poor mental health days per month and tracks how the rankings have shifted since 2014. It also examines whether depression diagnosis rates follow the same geographic pattern.
Medicare Markup: Who Charges the Most vs. Gets Paid
Which medical specialties submit the most inflated charges to Medicare? We analyze the gap between billed charges and actual payments across all provider types, 2013–2023.
Loneliness & Health: What BRFSS 2024 Data Reveals
Explore how loneliness and lack of emotional support connect to poor mental health, chronic disease, and missed care using BRFSS 2024 survey data.
Medicaid Telehealth Billing Surge: Before vs. After COVID-19
Analyzing Medicaid telehealth procedure code spending from 2018–2024 reveals dramatic shifts in provider adoption, patient reach, and total dollars billed.
Highest Per-Patient PCM Billers in Medicaid (100+ Patients)
Which Medicaid providers bill the most per patient for Principal Care Management? We rank providers with 100+ PCM patients by average spending per beneficiary.
Medicaid RPM Spending Trends: 2018–2024 Year Over Year
Explore how Medicaid remote patient monitoring spending has grown year over year from 2018 to 2024, including top billing providers and procedure code breakdowns.
Which Medicaid Providers Bill Only One Procedure Code?
Discover how many Medicaid providers bill exclusively one HCPCS code, what those codes are, and what this reveals about care specialization vs. potential fraud.
The Top 10 Highest-Spending Medicaid Procedures in 2024
Analysis of the highest-cost Medicaid procedures in 2024, ranked by total spending from 227M+ claims records covering 617K+ providers.